chime finl inc - CHYM
CHYM
Close Chg Chg %
24.95 0.97 3.89%
Closed Market
25.92
+0.97 (3.89%)
Volume: 9.45M
Last Updated:
Aug 5, 2026, 4:00 PM EDT
Company Overview: chime finl inc - CHYM
CHYM Key Data
| Open $25.00 | Day Range 24.91 - 26.22 |
| 52 Week Range 15.88 - 33.97 | Market Cap $8.76B |
| Shares Outstanding 381.02M | Public Float 167.73M |
| Beta 0.32 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$2.61 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 5.38M |
CHYM Performance
| 1 Week | 12.74% | ||
| 1 Month | 24.20% | ||
| 3 Months | 40.68% | ||
| 1 Year | -10.28% | ||
| 5 Years | N/A |
CHYM Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
23
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | Average Target Price | 30.00 | |
| Number of Ratings | 23 | Current Quarters Estimate | 0.058 | |
| FY Report Date | 09 / 2026 | Current Year's Estimate | 0.322 | |
| Last Quarter’s Earnings | N/A | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -4.27 | Next Fiscal Year Estimate | 0.739 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 15 | 15 | 17 | 17 |
| Mean Estimate | 0.06 | 0.13 | 0.32 | 0.74 |
| High Estimates | 0.09 | 0.16 | 0.41 | 1.32 |
| Low Estimate | 0.01 | 0.10 | 0.23 | 0.53 |
| Coefficient of Variance | 34.99 | 14.78 | 15.23 | 26.59 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 18 | 18 | 18 |
| OVERWEIGHT | 1 | 1 | 0 |
| HOLD | 3 | 3 | 3 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Chime Finl Inc - CHYM
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Chime Finl Inc - CHYM
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 20, 2026 | Adam B. Frankel General Counsel | 209,662 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.69 per share | 4,128,244.78 |
| Feb 20, 2026 | Mark T. Troughton President | 2,679,727 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.69 per share | 52,763,824.63 |
| Feb 20, 2026 | Ryan King Co-Founder; Director | 147,148 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.69 per share | 2,897,344.12 |
| Feb 20, 2026 | Ryan King Co-Founder; Director | 140,001 | Bona fide gift | 0.00 |
| Feb 20, 2026 | Ryan King Co-Founder; Director | 29,622 | Bona fide gift | 0.00 |
| Feb 20, 2026 | Christopher R. Britt Chief Executive Officer; Director | 296,548 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.69 per share | 5,839,030.12 |
| Feb 20, 2026 | Christopher R. Britt Chief Executive Officer; Director | 282,501 | Bona fide gift | 0.00 |
| Feb 20, 2026 | Christopher R. Britt Chief Executive Officer; Director | 52,785 | Bona fide gift | 0.00 |
| Feb 20, 2026 | Matthew Newcomb Chief Financial Officer | 396,120 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.69 per share | 7,799,602.80 |
| Feb 20, 2026 | Matthew Newcomb Chief Financial Officer | 373,597 | Bona fide gift | 0.00 |
| Feb 20, 2026 | Matthew Newcomb Chief Financial Officer | 2,263,321 | Bona fide gift | 0.00 |
| Feb 20, 2026 | Amine Asmerom Chief Accounting Officer | 211,213 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.69 per share | 4,158,783.97 |
| Dec 23, 2025 | Crosslink Capital, Inc. Director | 7,112,669 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $26.77 per share | 190,406,149.13 |
| Dec 23, 2025 | Crosslink Capital, Inc. Director | 7,044,936 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $27.69 per share | 195,074,277.84 |